187 related articles for article (PubMed ID: 25645622)
1. Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity.
Lee SA; Kim H; Won YS; Seok SH; Na Y; Shin HB; Inn KS; Kim BJ
Mol Cancer; 2015 Feb; 14(1):23. PubMed ID: 25645622
[TBL] [Abstract][Full Text] [Related]
2. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
3. Sex disparity in viral load, inflammation and liver damage in transgenic mice carrying full hepatitis B virus genome with the W4P mutation in the preS1 region.
Lee SA; Lee SY; Choi YM; Kim H; Kim BJ
World J Gastroenterol; 2018 Mar; 24(10):1084-1092. PubMed ID: 29563753
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antitumor activity of Artemisia capillaris extract against hepatocellular carcinoma through the inhibition of IL-6/STAT3 signaling axis.
Jang E; Kim SY; Lee NR; Yi CM; Hong DR; Lee WS; Kim JH; Lee KT; Kim BJ; Lee JH; Inn KS
Oncol Rep; 2017 Jan; 37(1):526-532. PubMed ID: 28004112
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
8. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.
Mun HS; Lee SA; Kim H; Hwang ES; Kook YH; Kim BJ
J Virol; 2011 Jan; 85(1):123-32. PubMed ID: 20962085
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma.
Deng M; Hou J; Hu J; Wang S; Chen M; Chen L; Ju Y; Li C; Meng S
Cancer Lett; 2016 Dec; 383(1):62-72. PubMed ID: 27693636
[TBL] [Abstract][Full Text] [Related]
10. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Hu Z; Luo D; Wang D; Ma L; Zhao Y; Li L
Cell Physiol Biochem; 2017; 43(6):2379-2390. PubMed ID: 29073625
[TBL] [Abstract][Full Text] [Related]
11. Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.
Lee SA; Kim KJ; Kim DW; Kim BJ
J Clin Microbiol; 2013 Dec; 51(12):3928-36. PubMed ID: 24025913
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
14. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
Viruses; 2021 May; 13(5):. PubMed ID: 34066744
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and hepatitis B surface protein.
Li YW; Yang FC; Lu HQ; Zhang JS
World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
20. Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis.
Zheng J; Jiang S; Lu F
Jpn J Infect Dis; 2016 Jul; 69(4):306-13. PubMed ID: 26567840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
